Peterson LB et al. |
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. |
1998 |
Transplantation |
pmid:9448137
|
Dumont FJ et al. |
A tacrolimus-related immunosuppressant with reduced toxicity. |
1998 |
Transplantation |
pmid:9448138
|
Mieles L et al. |
Interaction between FK506 and clotrimazole in a liver transplant recipient. |
1991 |
Transplantation |
pmid:1721250
|
Levy G et al. |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. |
2004 |
Transplantation |
pmid:15201658
|
Roth D et al. |
A prospective study of hepatitis C virus infection in renal allograft recipients. |
1996 |
Transplantation |
pmid:8623154
|
Adams PS et al. |
Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome. |
2013 |
Transplantation |
pmid:23380870
|
Ajiki T et al. |
Generation of donor hematolymphoid cells after rat-limb composite grafting. |
2003 |
Transplantation |
pmid:12640301
|
Tsuchiya N et al. |
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2004 |
Transplantation |
pmid:15502717
|
Rodrigo E et al. |
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. |
2016 |
Transplantation |
pmid:26703349
|
Takahara S et al. |
The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. |
1992 |
Transplantation |
pmid:1373537
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
David-Neto E et al. |
The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. |
2007 |
Transplantation |
pmid:17627237
|
Al-Uzri A et al. |
Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). |
2001 |
Transplantation |
pmid:11579294
|
Roy A et al. |
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. |
2006 |
Transplantation |
pmid:16926593
|
Welberry Smith MP et al. |
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. |
2013 |
Transplantation |
pmid:24056618
|
Yang Z et al. |
Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. |
2003 |
Transplantation |
pmid:12589149
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
Zhao WY et al. |
Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. |
2014 |
Transplantation |
pmid:25955345
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Andoh TF et al. |
Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. |
1994 |
Transplantation |
pmid:7509514
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Mathis AS et al. |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. |
2001 |
Transplantation |
pmid:11374405
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Mañez R et al. |
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. |
1995 |
Transplantation |
pmid:7537400
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Chapman WC et al. |
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. |
2017 |
Transplantation |
pmid:28121741
|
Pascual M et al. |
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. |
1998 |
Transplantation |
pmid:9869086
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Becker T et al. |
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. |
2008 |
Transplantation |
pmid:19104406
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Borni-Duval C et al. |
Risk factors for BK virus infection in the era of therapeutic drug monitoring. |
2013 |
Transplantation |
pmid:23778568
|
Charpentier B et al. |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. |
2003 |
Transplantation |
pmid:12660513
|
Anil Kumar MS et al. |
Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. |
2005 |
Transplantation |
pmid:16210969
|
Jain A et al. |
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. |
2005 |
Transplantation |
pmid:16210976
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Mourer JS et al. |
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients. |
2012 |
Transplantation |
pmid:22955227
|
Ellis D et al. |
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. |
2007 |
Transplantation |
pmid:17589338
|
Florman S et al. |
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. |
2007 |
Transplantation |
pmid:17589349
|
Webb NJ et al. |
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. |
2015 |
Transplantation |
pmid:25539467
|
Yoo MC et al. |
Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. |
2015 |
Transplantation |
pmid:25539464
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Vincenti F et al. |
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8669100
|
Dean PG et al. |
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. |
2004 |
Transplantation |
pmid:15239621
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Rayar M et al. |
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes. |
2018 |
Transplantation |
pmid:29315140
|
Gillard P et al. |
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. |
2008 |
Transplantation |
pmid:18212631
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|